ImportRefusal LogoImportRefusal

GP Grenzach Produktions GmbH

⚠️ Moderate Risk

FEI: 3006308309 • Grenzach-Wyhlen, Baden-Wurttemberg • GERMANY

FEI

FEI Number

3006308309

📍

Location

Grenzach-Wyhlen, Baden-Wurttemberg

🇩🇪

Country

GERMANY
🏢

Address

Emil-Barell-Str. 7, , Grenzach-Wyhlen, Baden-Wurttemberg, Germany

Moderate Risk

FDA Import Risk Assessment

32.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

6
Total Refusals
8
Unique Violations
7/12/2016
Latest Refusal
11/12/2010
Earliest Refusal

Score Breakdown

Violation Severity
55.0×40%
Refusal Volume
31.3×30%
Recency
0.0×20%
Frequency
10.6×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3364×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1183×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4722×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3441×

WARNINGS

It appears to lack adequate warning against use in a pathological condition or by children where it may be dangerous to health or against an unsafe dose, method, administering duration, application, in manner/form, to protect users.

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

Refusal History

DateProductViolationsDivision
7/12/2016
63NBO04DEXPANTHENOL (CHOLINERGIC)
75UNAPPROVED
Los Angeles District Office (LOS-DO)
8/19/2014
61WBO04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
3280FRNMFGREG
336INCONSPICU
472NO ENGLISH
75UNAPPROVED
Southwest Import District Office (SWI-DO)
9/10/2013
61WBO04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
16DIRECTIONS
336INCONSPICU
344WARNINGS
472NO ENGLISH
75UNAPPROVED
Southwest Import District Office (SWI-DO)
10/31/2011
61WAJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
336INCONSPICU
Southwest Import District Office (SWI-DO)
10/31/2011
61WAJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC)
118NOT LISTED
336INCONSPICU
Southwest Import District Office (SWI-DO)
11/12/2010
54ACA99VITAMIN, N.E.C.
324NO ENGLISH
New York District Office (NYK-DO)

Frequently Asked Questions

What is GP Grenzach Produktions GmbH's FDA import refusal history?

GP Grenzach Produktions GmbH (FEI: 3006308309) has 6 FDA import refusal record(s) in our database, spanning from 11/12/2010 to 7/12/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GP Grenzach Produktions GmbH's FEI number is 3006308309.

What types of violations has GP Grenzach Produktions GmbH received?

GP Grenzach Produktions GmbH has been cited for 8 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GP Grenzach Produktions GmbH come from?

All FDA import refusal data for GP Grenzach Produktions GmbH is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.